PT Diagnos Laboratorium Utama Tbk (DGNS.JK)

IDR 210.0

(0.0%)

Operating Expenses Summary of PT Diagnos Laboratorium Utama Tbk

PT Diagnos Laboratorium Utama Tbk's latest annual operating expenses in 2023 was 72.8 Billion IDR , up 2.91% from previous year.
PT Diagnos Laboratorium Utama Tbk's latest quarterly operating expenses in 2024 Q1 was 16.19 Billion IDR , down -8.19% from previous quarter.
PT Diagnos Laboratorium Utama Tbk reported a annual operating expenses of 70.73 Billion IDR in annual operating expenses 2022, up 6.59% from previous year.
PT Diagnos Laboratorium Utama Tbk reported a annual operating expenses of 66.36 Billion IDR in annual operating expenses 2021, up 251.63% from previous year.
PT Diagnos Laboratorium Utama Tbk reported a quarterly operating expenses of 15.14 Billion IDR for 2024 Q2, down -6.48% from previous quarter.
PT Diagnos Laboratorium Utama Tbk reported a quarterly operating expenses of 15.54 Billion IDR for 2023 Q2, down -10.39% from previous quarter.

Annual Operating Expenses Chart of PT Diagnos Laboratorium Utama Tbk (2023 - 2017)

Historical Annual Operating Expenses of PT Diagnos Laboratorium Utama Tbk (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	72.8 Billion IDR	2.91%
2022	70.73 Billion IDR	6.59%
2021	66.36 Billion IDR	251.63%
2020	18.87 Billion IDR	200.43%
2019	6.28 Billion IDR	53.36%
2018	4.09 Billion IDR	48.25%
2017	2.76 Billion IDR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	16.19 Billion IDR	-8.19%
2024 Q2	15.14 Billion IDR	-6.48%
2023 Q2	15.54 Billion IDR	-10.39%
2023 Q3	15.13 Billion IDR	-2.63%
2023 Q1	17.34 Billion IDR	-17.5%
2023 FY	65.67 Billion IDR	-7.16%
2023 Q4	17.64 Billion IDR	16.53%
2022 Q4	21.02 Billion IDR	17.19%
2022 Q3	17.94 Billion IDR	28.68%
2022 Q2	13.94 Billion IDR	-21.16%
2022 FY	70.73 Billion IDR	6.59%
2022 Q1	17.68 Billion IDR	-16.36%
2021 Q1	16.97 Billion IDR	192.64%
2021 FY	66.36 Billion IDR	251.63%
2021 Q4	21.14 Billion IDR	59.78%
2021 Q2	15 Billion IDR	-11.63%
2021 Q3	13.23 Billion IDR	-11.77%
2020 Q4	5.8 Billion IDR	17.47%
2020 Q1	4.88 Billion IDR	139.14%
2020 FY	18.87 Billion IDR	200.43%
2020 Q2	2.87 Billion IDR	-41.17%
2020 Q3	4.93 Billion IDR	71.73%
2019 Q3	2.04 Billion IDR	45.24%
2019 Q2	1.4 Billion IDR	0.0%
2019 FY	6.28 Billion IDR	53.36%
2019 Q1	1.4 Billion IDR	0.0%
2019 Q4	2.04 Billion IDR	0.0%
2018 FY	4.09 Billion IDR	48.25%
2017 FY	2.76 Billion IDR	0.0%

Peer Operating Expenses Comparison of PT Diagnos Laboratorium Utama Tbk

Name	Operating Expenses	Operating Expenses Difference
PT Prodia Widyahusada Tbk	956.86 Billion IDR	92.392%